Insignia Capital buys Metanexgen

Insignia Capital Group has acquired Bensalem, Pennsylvania-based Metanexgen, a provider of multi-channel marketing solutions for the pharmaceutical, biotech and medical device sectors. The sellers included DFW Capital Partners. No financial terms were disclosed.

DealsNorth AmericaUSBriefs